Engrail Therapeutics, Inc.

Paul Cayer signed Engrail Therapeutics, Inc.'s 2024 Form 5500 as plan administrator.

• Paul Cayer — Plan Administrator — Form 5500 signer

Signer names are public record from the Form 5500 e-signature.

Engrail Therapeutics, Inc.'s EIN is 84-2517846.

Download the official 2024 Form 5500 (PDF) for Engrail Therapeutics, Inc. from the U.S. Department of Labor's EFAST2 system.

Engrail Therapeutics, Inc.'s plan includes profit-sharing, ERISA 404(c) participant direction, a 401(k) feature, a default investment (QDIA).